1.
Kaveh S, Ebrahimi P, Rezapour A, Mozafari M, Sayehmiri K. Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer. Int Pharm Acta [Internet]. 2018 Mar. 4 [cited 2024 May 7];1(1):19-20. Available from: https://journals.sbmu.ac.ir/acta/article/view/20015